Results 91 to 100 of about 141,614 (292)

Neutrino mixing and CP-violation [PDF]

open access: yesNuclear Physics B, 2000
22 pages, LaTeX2e, 17 eps files, use package ...
DONINI A   +3 more
openaire   +5 more sources

Crossing and Anticrossing of Exchange‐Coupled Molecular Spin Excitation Energy Levels

open access: yesSmall, EarlyView.
Orientation matters: The excitation energy levels of exchange‐coupled spins of two nickelocene molecules anchored to superconducting electrodes are explored via inelastic electron tunneling spectroscopy. Depending on the tilt angle of the single‐molecule magnetic probe the levels cross or exhibit avoided crossing. Abstract The superconducting Pb tip of
Lorenz Meyer   +4 more
wiley   +1 more source

CP Violation for B0→ρ0(ω)ρ0(ω)→π+π-π+π- in QCD Factorization

open access: yesAdvances in High Energy Physics, 2014
In the QCD factorization (QCDF) approach we study the direct CP violation in B-0→ρ0(ω)ρ0(ω)→π+π-π+π- via the ρ-ω mixing mechanism. We find that the CP violation can be enhanced by double ρ-ω mixing when the masses of the π+π- pairs are in the vicinity of
Gang Lü, Jia-Qi Lei, Xin-Heng Guo
doaj   +1 more source

CP VIOLATION IN HYPERON DECAYS [PDF]

open access: yesB Physics and CP Violation, 2000
Presented at the CP Violation Workshop, Adeleide, july 3-8 ...
openaire   +6 more sources

CP violation and neutrino oscillations [PDF]

open access: yesProgress in Particle and Nuclear Physics, 2008
We review the basic mechanisms of neutrino mass generation and the corresponding structure of the lepton mixing matrix. We summarize the status of three-neutrino oscillation parameters as determined from current observations, using state-of-the-art solar and atmospheric neutrino fluxes, as well as latest experimental data as of September 2007.
Nunokawa, Hiroshi   +2 more
openaire   +5 more sources

Nanoparticle Therapeutics in Clinical Perspective: Classification, Marketed Products, and Regulatory Landscape

open access: yesSmall, EarlyView.
This review presents a detailed overview of clinically approved nanoparticle therapeutics, classifying them by type and discussing their unique advantages in drug delivery. It highlights regulatory challenges across global markets and emphasizes the need for adaptive approval pathways.
Nimeet Desai   +5 more
wiley   +1 more source

CP violation in loop-induced diboson production

open access: yesJournal of High Energy Physics
We consider the impact of CP-violating Higgs and top interactions on diboson production from gluon fusion within the Standard Model Effective Field Theory framework.
Marion O. A. Thomas, Eleni Vryonidou
doaj   +1 more source

COVID‐19 Vaccine Mandates in Southeast Asia: A Comparative Study of Policies in Malaysia, the Philippines, Thailand, and Vietnam

open access: yesWorld Medical &Health Policy, EarlyView.
ABSTRACT The COVID‐19 pandemic precipitated a global emergency and governments employed various strategies to increase COVID‐19 vaccine coverage across the population, including vaccine mandates. No comparative study has evaluated the development, implementation, and structure of COVID‐19 mandatory vaccination policies in the Southeast Asia region ...
Nor Kamila Kamaruzaman   +9 more
wiley   +1 more source

Lattice QCD spectroscopy for hadronic CP violation

open access: yesPhysics Letters B, 2017
The interpretation of nuclear electric dipole moment (EDM) experiments is clouded by large theoretical uncertainties associated with nonperturbative matrix elements.
Jordy de Vries   +3 more
doaj   +1 more source

Becoming a University President: An Accidental Meritocratic Career Trajectory

open access: yesBritish Journal of Management, EarlyView.
Abstract Achieving top leadership positions is a career goal for many, including those in academia. Despite the increasing size and importance of the higher education sector, the literature on university presidents' careers remains scarce. We interviewed 48 university presidents in three academic models (UK, France, and Vietnam) to identify the ‘why ...
Yehuda Baruch   +3 more
wiley   +1 more source

Home - About - Disclaimer - Privacy